Utah NASA Space Grant Consortium Fellowship Symposium Proceedings
May 2019

Administering Model-based Patient-specific Supplemental
Oxygen Therapy
Kyle M. Burk1,2
Joseph A. Orr1,2

Abstract Purpose: The oxyhemoglobin dissociation
curve describes the relationship between the partial pressure of oxygen and the percent of hemoglobin saturated with oxygen and varies with chemical and physical factors that differ for every patient. If variability
could be determined, patient specific oxygen therapy
could be administered. We have developed a procedure for characterizing variations in the oxygen dissociation curve. The purpose of this study was to validate this procedure in surgical patients. Methods: The
procedure uses an automated system to alter oxygen
therapy and Hill’s equation to fit measurements. Once
measurements are gathered, the procedure uses an iterative least-squares method to determine best-fit parameters for the Hill equation. The procedure was performed on surgical patients after which model fit was
assessed. Results: 39 patients participated in this study.
Using patient-specific parameter values increases correlation when compared to standard values. The procedure improved the model fit of patient saturation values
significantly in 19 patients. Conclusions: This paper
has demonstrated a procedure for determining patientspecific pulse oximeter response. This procedure determined best-fit parameters resulting in a significantly
improved fit when compared to standard values. These
best-fit parameters increased the coefficient of determination R2 in all cases.
Keywords Subject-specific modeling · Non-linear
least-squares · Oxygen saturation response · The Hill
equation
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1 Introduction
The oxyhemoglobin dissociation curve (ODC) describes the relationship between the percent of hemoglobin
saturated with oxygen (SHbO2) and the partial pressure of oxygen (PO2) in the blood [12, 7, 15, 6, 8]. Due to
the allosteric effects of oxygen binding with hemoglobin’s
four oxygen binding sites, this response is a sigmoidal
curve [13, 3]. Due to hemoglobin’s affinity for oxygen,
this sigmoid relationship plateaus at a PO2 of approximately 150 mm Hg in healthy patients [12]. Above 150
mm Hg the majority of hemoglobin binding sites are
fully saturated with oxygen, and thus SHbO2 is minimally responsive to changes in PO2 while below 150
mm Hg SHbO2 is highly responsive to changes in PO2
[1]. These characteristics of oxyhemoglobin’s response
to PO2 permit oxygen uptake in the lungs, at high PO2,
and oxygen unloading near tissue, at low PO2, and are
vital to oxygen transport in the body [9].
Besides oxygen, hemoglobin is responsive to other
notable allosteric effectors [7, 17, 19, 20]. These include
chemical factors in the blood such as hydrogen ions
(pH), carbon dioxide (CO2), and 2,3-Diphosphoglycerate
(2,3-DPG) [5]. Hemoglobin’s allosteric effectors also include the physical factor of temperature (T ). Although
the effects of factors are well characterized, the values of
the factors are not clinically available in many patients.
Patient to patient variation in the concentrations and
levels of these effectors, in turn, can effect hemoglobin’s
affinity for oxygen. Differences in oxygen affinity can affect the position and shape of the ODC, with increased
oxygen affinity shifting the curve to the left (lower PO2)
and decreased affinity shifting the curve to the right
[12]. Thus, hemoglobin’s affinity for oxygen varies from
patient to patient [18].
Variations in oxygen affinity change the shift and
shape of the ODC, including the PO2 at which the
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ODC transitions from a plateau to a steep slope. This
patient-to-patient variability impacts the level of oxygen therapy required to prevent desaturation. However,
if a patient-specific ODC could be generated, the transition from the plateau to sharp curve could be characterized, and patient-specific oxygen therapy could be
administered, preventing desaturation. One possibility
for determining patient variability is to create an automated procedure which uses a set of PO2 and pulse
oxygen saturation (SpO2) value pairs to fit a patientspecific ODC. We have developed such a procedure which
is based on an automated oxygen delivery system and
Hill’s equation.
The procedure measures several levels of oxygen saturation by varying oxygen therapy using an automated
system. Best-fit parameters (P50 , n, K) for corresponding saturation and oxygen measurements are then found
using an iterative minimal least-squares technique. Once
these parameters are found, the procedure constructs a
patient-specific ODC from which important characteristics, including the transition from the plateau to the
steep slope of the curve, can be obtained. Extrapolation
of the ODC could also be used to predict a patientspecific response to different levels of oxygen therapy.
The objective of this study was to validate the procedure for determining patient-specific pulse oxygen saturation response. If validated, the procedure could characterize patient-specific oxyhemoglobin using an automated system and non-invasive techniques.

2 Methods
This study was performed in accordance with the
1964 Helsinki declaration and its later amendments or
comparable standards. Study approval came from the
University of Utah Institutional Review Board. All patients participated with written informed consent.

2.1 Procedure for characterizing oxygen saturation
response
The procedure for characterizing pulse oxygen saturation response uses an automated system to alter
oxygen therapy to generate patient-specific oxygen flow
and saturation data pairs. Hill’s equation is then used to
characterize the data set for each patient. To determine
oxygen saturation response, the automated system administers different levels of oxygen therapy gathering
measurements for oxygen and saturation levels at each
level. The procedure then uses iterative least squares
residual techniques to find the best-fit curve for the
gathered measurements.
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Fig. 1 Schematic diagram of the automated system

2.1.1 Automated oxygen therapy system
Figure 1 shows a schematic diagram of the automated oxygen therapy system which includes a laptop
computer. The automated system varies oxygen flow
rate using a proportional solenoid valve (MD PRO,
Parker Hannifin, Hollis, NH) connected to a compressed
oxygen source. A laptop computer collects end-tidal
oxygen (etO2) measurements from a gas analyzer (CapnoMAC, Datex, Helsinki, Finland). The laptop computer also collects SpO2 from a pulse oximeter (LNCSTM ,
Masimo, Irvine, CA). The system monitored nasal pressure to determine breath phase, and discontinued oxygen flow during exhalation so that etO2 measurements
were not contaminated by supplemental oxygen.

2.1.2 Theoretical aspects
While varying oxygen, the procedure collects pairs
of etO2 and SpO2 measurements. Since the system varies
oxygen, a range of SpO2 measurements can be measured to characterize a patient’s ODC. After collecting
pairs of measurements, the procedure fits the data to
Hill’s equation:
SHbO2 = f (P O2) = K

(P O2/P50 )n
,
1 + (P O2/P50 )n

(1)

where P50 is the P O2 at which 50% of hemoglobin are
saturated with oxygen (SHbO2 = 50%), n is the Hill
coefficient, and K is the maximum saturation possible.
Hill’s Equation can be used to calculate SHbO2 for
any given PO2. Its three variables can be used to determine ODC shift (P50 ), slope (n), and offset (K). The
value of these three variables depends on the conformation of hemoglobin and thus varies between patients.
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2.1.3 Determining the best-fit parameters

Table 1 Constraints for x = {P50 , n, K}

The procedure finds the best fit P50 , n, and K values for each volunteer using iterative non-linear leastsquares fitting as implemented in the least squares function of the optimize module in SciPy (SciPy, v1.1.0,
The SciPy community) [14].
The solution to a non-linear least-squares problem
is a local minimizer of the problem:

min{

m
X

fi (x)2 },

(2)

i=1

where m is the number of residuals [2]. For analyzing
pulse oxygen saturation response, the problem is of the
form:
fi (x) = K

(P O2i /P50 )n
− SpO2i ,
1 + (P O2i /P50 )n

(3)

where P O2i (independent) and SpO2i (dependent) are
the ith measured SpO2 and etO2 points, respectively.
The patient-specific parameters are contained in x =
{P50 , n, K}. The Jacobian matrix, which is helpful for
computing the minimization problem, can be found using the following equations:

Parameter
P50
n
K

Range

Units

15 - 75
1.5 - 3.9
0.94 - 1.0

mm Hg
unitless
unitless

2.2 Model fit assessment
Model fit assessment methods can be used to quantify how well the model performs. These assessment
methods analyze how well the model describes data (descriptive error) and how well it predicts data (predictive error). For modeling oxygen saturation response,
model description and prediction error can be analyzed
to validate the ability of the procedure to fit and predict
SpO2.
Descriptive error can be determined by calculating
the coefficient of determination R2 :
Pn
2
2
i=1 (yi − f (xi ))
R =1− P
,
(8)
n
2
i=1 (yi − y)
where f is the Hill equation with best-fit parameters
for the particular data set x, f (xi ) represents model
estimates computed using f and xi , yi are observed
measurements, and y is the mean of all the yi measurements:
n

Ji1

∂fi
Kn
(P O2i /P50 )n
Ji0 =
=−
∂P50
P50 [1 + (P O2i /P50 )n ]2
∂fi
(P O2i /P50 )n
=
= Klog(P O2i /P50 )
∂n
[1 + (P O2i /P50 )n ]2
∂fi
(P O2i /P50 )n
Ji2 =
=
∂K
1 + (P O2i /P50 )n

(4)
(5)
(6)

where log is the natural logarithm and values in x are
all positive. The constraints for x are shown in Table 1.

2.1.4 Estimating oxygen saturation
After the best-fit parameters have been determined
using the methods described in Section 2.1.3, the procedure proceeds by estimating oxygen saturation. This
is done using the best-fit parameters, etO2 values, and
Equation (1). End-tidal oxygen values are converted to
PO2 by compensating for local atmospheric pressure
(640 mm Hg) and the partial pressure of water vapor
at 37o C (47 mm Hg):

P O2 = (640 − 47)

etO2
mm Hg
100%

(7)

y=

1X
yi
n i=1

(9)

Leave-one-out cross-validation can be performed by
calculating the predictive coefficient of determination
Q2 :
Pn
(yi − f(−i) (xi ))2
Pn
Q2 = 1 − i=1
,
(10)
2
i=1 (yi − y)
where f−i (xi ) represents the value at xi produced when
the best-fit parameters were calculated by leaving out
xi . Cross-validation calculates Q2 by using Equation
(10) to loop through each measurement for a given data
set, leaving out one data point each time, using the remaining data points to determine the best fit model
parameters, and using those best-fit parameters to predict the point left out.

2.3 Study setup and protocol
Participants were selected from surgical patients at
the University of Utah Moran Eye Center. Potential
participants were selected by a chart review before surgery.
Eligible participants had an adult American Society of
Anesthesiologists physical status of I-III and were aged
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> 18 yr. Patients with a baseline SpO2 ≤ 93% on room
air, surgery scheduled for less than 20 minutes, ARDS,
lung disease, cardiovascular disease, or pregnancy were
not eligible to participate.
Before the surgery, participants were fitted with a
sampling nasal cannula and the automated system’s
pulse oximeter. The sampling line of the nasal cannula was connected to the system’s gas analyzer. During the procedure, the automated system administered
oxygen at varying flow rates. Each flow rate was administered for two minutes after which etO2 and SpO2
were recorded. Given that surgery time would vary between patients we expected to acquire a different number of paired measurements for each patient. Once the
surgery concluded and all paired measurements for a
patient were collected data analysis proceeded as described in Sections 2.1.3 and 2.1.4. Once best-fit parameters had been determined and oxygen saturation
estimated model fit was assessed as described in Section 2.2. For comparison, fit for a model using generic
parameter values, x = {26.8, 2.7, 1.0}, was also assessed
using Equation 8.

2.4 Statistical analysis
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Table 2 Median and dispersion of optimal values for P50 , n,
and K
Parameter

Mean (SD)

Range (Min. - Max.)

Units

P50
n
K

32.0 (14.4)
3.2 (0.8)
1.00 (0.01)

53.4 (15.0 - 68.4)
2.2 (1.67 - 3.9)
0.06 (0.94 - 1.00)

mm Hg
unitless
unitless


F =

RSSstd −RSSspec
pspec −pstd



RSSspec
n−pspec




,

(13)

where RSSstd and RSSspec are the residual sum of
squares (RSS) when using the standard and specific
curves respectively, pstd = 0 and pspec = 3 are the number of parameters in the standard and specific models
respectively, and n is the number of data points. The
specific model fit was significantly improved if F calculated using (13) was greater than the critical value of
the F-distribution with (pspec − pstd ,n − pspec ) degrees
of freedom and α = 0.05.
3 Results

39 patients participated in this study. 498 data points
Statistical analysis was performed using Python (v2.7.14,
were evaluated with an average of 12 data points per paPython Software Foundation, Beaverton, OR). Median
tient. The median values as well as standard deviation
R2 and Q2 across all patients was calculated. The in(SD) and range for P50 , n, and K are shown in Table
terquartile range (IQR), including 25th and 75th per2. For 19 of the 39 patients, a specific ODC improved
centiles, was used to report uncertainty.
model-fit significantly (F > F -critical).
Differences between measurements yi and model outFigure 2 shows the model fit for a typical patient.
put f (xi ) were compared for both descriptive and preThe best fit parameters for this particular patient were
dictive modeling using limits of agreement (LoA) methx = {24.9, 1.9, 0.99}. When performing leave-one-out
ods. The absolute difference between measurements yi
analysis, the mean ± SD for the best fit parameters was
and model output f (xi )/f(−i) (xi ) is the residual and
x = {25.0±1.6, 1.9±0.1, 0.99±0.001}. Using a patientwas calculated for all measurements:
specific ODC to fit patient data points increased correlation (R2 : 0.94 vs. -2.36, specific vs. generic) and imf (xi ) − yi
(11)
proved model fit significantly (F > F -critical). Leaveone-out analysis also showed increased correlation (Q2 =
0.92). This patient-specific curve shows how oxygen satf(−i) (xi ) − yi
(12)
uration would begin to drop long before a standard
LoA methods calculated the mean difference of all data
ODC would predict. For example, oxygen saturation
points using (11) or (12). 95% LoA were calculated as
at 70 mm Hg for the standard curve is 0.93 while for
±1.96 SD where SD is the standard deviation of the
the patient-specific curve it is 0.87.
difference between all data points. To determine difThe coefficient of determination R2 for all patients
ferences between predictive and descriptive modeling,
are shown in Figure 3. Using patient-specific paramthe LoA for descriptive and predictive modeling were
eter values resulted in increased correlation compared
compared.
to standard values (median (IQR) R2 : 0.42 (0.63) vs.
For each patient an F-test was used to determine
-0.22 (2.08), specific vs. standard). The median differif the specific fit improved model-fit significantly comence (specific - standard) in R2 for paired data was 0.85
pared to a standard ODC. The F-statistic F was calwith an interquartile range from 0.29 to 1.90. The meculated as:
dian absolute difference between modeled data points
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Fig. 2 Model fit and prediction for a select patient. For
this particular patient, the best fit values were x =
{24.9, 1.9, 0.99}. Correlation increased when using a specific
oxyhemoglobin dissociation curve (R2 : 0.94 vs. -2.36, specific
vs. standard). Leave-one-out analysis also showed increased
correlation (Q2 = 0.92)

Fig. 3 Coefficient of determination R2 /Q2 when model parameters are set to standard values compared to when model
parameters are set to best-fit values. The upper panel shows
an expanded view of all R2 /Q2 values while the lower panel
shows a magnified view centered on the R2 /Q2 range from 0
to 1

f (xi ) and observed measurements yi for all patients
was -0.0005 SpO2. The 95% LoA were from -0.0149 to
0.0140 SpO2 (Figure 4).
The predictive coefficient of determination Q2 for
all patients are shown in Figure 3. The median (IQR)
Q2 was 0.07 (0.81). The median absolute difference between predicted data points f(−i) (xi ) and observed measurements yi for all patients was -0.0005 SpO2. The 95%
LoA were from -0.0189 to 0.0179 SpO2 (Figure 4).

[4, 11]. Brockway et al. found that PaO2 correlated significantly with SpO2. This research has added to these
results by demonstrating increased correlation when determining patient-specific parameter values.
As expected, the mean best-fit values for model parameters (Table 2) compared well with typical standard
values. However, a wide range of parameter values was
observed when considering the patient population as a
whole. This wide range demonstrates the utility in determining patient-specific parameter values to predict
oxygen saturation response.
For some of the parameters, the upper or lower parameter constraint was reached in at least one patient.
Two bounds of particular interest for which this occurred were the lower bound of P50=15 and the upper
bound of n = 3.9. Had the constraint window for these
parameters been broader correlation may have been improved but the parameter value may not have been
physiologically realistic. This demonstrates the balance
between improved model fit and physiologically realistic results. The proper range for realistic constraint
windows on P50, n, and K should be explored further
and considered in future research on oxygen saturation
response.
When predicting SpO2, as simulated using leaveone-out cross-validation, this procedure exhibited larger
LoA compared to descriptive modeling. This result indicates that the predictive capability of the procedure
depends on the number of measurements acquired, with
the predictive capability of the procedure increasing
with the number of measurements. Therefore, the number of measurements acquired may influence the accuracy of the procedure’s predictions and thus the proce-

4 Discussion
This manuscript describes a procedure for determining a patient-specific pulse oxygen saturation response.
Results have shown that the procedure improved the
model fit of patient saturation values significantly in
19 of 39 patients. Results have also shown that using
patient-specific parameter values increases correlation
when compared to standard values. The predictive capability of the procedure was also tested, and results
show that the LoA when predicting were within ± 0.02
SpO2.
These results demonstrate the ability of the procedure to provide a more accurate estimate of patient
oxygen saturation response when compared with using standard parameter values. This accurate estimate
could help determine a patient’s specific response and
thus define the PO2 at which a patient’s SpO2 would
begin to decline rapidly. Further, this accurate estimate
could be used to describe the decline in SpO2 with time.
Previous related research has studied how accurately
SpO2 predicts arterial partial pressure of oxygen (PaO2)
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lations on different clinical scenarios that may not be
safe to study in volunteers or patients.

5 Conclusion
In summary, this paper has demonstrated and tested
a procedure for determining patient-specific pulse oxygen saturation response. The procedure was able to
determine best-fit parameters that resulted in significantly improved fit when compared to using standard
parameter values. These best-fit parameters increased
the coefficient of determination R2 in all cases.
Fig. 4 Bland-Altman analysis for descriptive and predictive
modeling. For descriptive modeling (left) the median absolute difference was -0.0005 SpO2 with 95% LoA from -0.0149
to 0.0140 SpO2. For predictive modeling (right) the median
absolute difference was -0.0005 SpO2 with 95% LoA from 0.0189 to 0.0179 SpO2
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dure should be used with care when circumstance only
allows for only a few paired measurements. However,
further research should be conducted to determine the
predictive capability of the procedure when using measurements with less error.
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